机构地区:[1]新疆医科大学第一附属医院风湿免疫科,新疆乌鲁木齐830054
出 处:《中国医药导报》2020年第25期168-171,192,共5页China Medical Herald
基 金:新疆维吾尔自治区自然科学基金资助项目(2019D01C327)。
摘 要:目的探讨以微信平台为核心的同伴支持对类风湿关节炎患者用药依从性及生活质量的影响。方法选择2017年8月-2018年6月在新疆医科大学第一附属医院风湿免疫科住院并符合纳入标准的类风湿关节炎患者为研究对象,采用类实验研究方法,将其按照入院先后顺序分为对照组(40例)和实验组(40例)。对照组实施常规出院健康宣教和门诊随访,实验组在此基础上采用院外6个月以微信平台为核心的同伴支持干预。比较两组出院后1、3、6个月的用药依从性、自我效能及生活质量得分情况。结果整体分析发现:两组出院后1、3、6个月的用药依从性、自我效能及生活质量得分组间比较、时间点比较及交互作用差异均有统计学意义(均P<0.05)。提示同伴支持可以提高患者用药依从性、增强自我效能和改善生活质量。实验组出院6个月服药依从性、自我效能及生活质量得分高于出院1、3个月,且出院3个月服药依从性、自我效能及生活质量得分高于出院1个月,差异均有统计学意义(均P<0.05);对照组出院6个月服药依从性、自我效能及生活质量得分低于出院1、3个月,且出院3个月服药依从性、自我效能及生活质量得分低于出院1个月,差异均有统计学意义(均P<0.05);实验组在出院1、3、6个月服药依从性、自我效能及生活质量得分均高于对照组,差异均有统计学意义(均P<0.05)。结论运用以微信平台为核心的同伴支持干预,可以提高患者的用药依从性、增强自我效能和改善生活质量。Objective To explore the effect of WeChat platform peer support on medication compliance and quality of life in patients with rheumatoid arthritis.Methods Patients with rheumatoid arthritis who were admitted to the Department of Rheumatology and Immunology,the First Affiliated Hospital of Xinjiang Medical University from August 2017 to June 2018 and who met the inclusion criteria were selected as study subjects,and they were divided into the control group(40 cases)and the experimental group(40 cases)according to the order of admission.The control group received routine health education after discharge and outpatient follow-up.On this basis,the experimental group adopted the peer support intervention with WeChat platform as the core for six months outside the hospital.The medication compliance,self-efficacy and life quality scores of the two groups at one,three and six months after discharge were compared.Results The overall analysis showed that there were statistically significant differences in medication compliance,self-efficacy,and quality of life between groups at one,three and six months after discharge(all P<0.05).It is suggested that peer support can improve patients′medication compliance,self-efficacy and quality of life.The scores of medication compliance,self-efficacy and quality of life in the experimental group at six months after discharge were higher than those at one and three months after discharge,and those at three months after discharge were higher than those at one month after discharge,with statistically significant differences(all P<0.05).In the control group,scores of medication compliance,self-efficacy and quality of life at six months after discharge were lower than those at one and three months after discharge,and scores of medication compliance,self-efficacy and quality of life at three months after discharge were lower than those at one month after discharge,with statistically significant differences(all P<0.05).The scores of medication compliance,self-efficacy and quality of life in
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...